What medtech companies is BlackRock buying into?
BlackRock Inc.
Vanguard, BlackRock buy into Boston Scientific’s turnaround
Count mutual fund giant Vanguard Group and hedge fund BlackRock Inc. among the believers in the comeback story at Boston Scientific (NYSE:BSX).
BlackRock boosts medical device stakes
BlackRock Inc., 1 of the world’s largest hedge funds, boosted its stake in a clutch of medical device companies, with 1 exception.
BlackRock pares 6% from Boston Scientific stake
Mammoth hedge fund BlackRock Inc. cut more than 4.5 million shares from its stake in medical device company Boston Scientific (NYSE:BSX), regulatory filings show.
BlackRock said it owned about 74.0 million shares as of July 31, according to the filings, down from 78.5 million as of Dec. 30, 2011.
Stryker readies $750M notes offering | Wall Street Beat
Stryker Corp. (NYSE:SYK) is readying a $750 million debt offering of five-year senior notes, little more than a week after inking a $135 million deal to acquire Concentric Medical Inc.
The Kalamazoo, Mich.-based orthopedics giant issued another massive round of debt notes early last year, offering $500 million in 5-year notes and $500 million in 10-year notes.
Medtronic, hacking, stocks, drug-eluting stents, antitrust charges, whistleblowers and insider trading made headlines this week. | MassDevice.com +7
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
Blackrock takes big position in Wright Medical
BlackRock becomes Smith & Nephew’s largest investor
BlackRock Inc. (NYSE:BLK) increased stake in British orthopedic device maker Smith & Nephew plc (NYSE:SNN) by some 2 million shares, making it the company’s single largest investor.
BlackRock, which previously owned 42 million shares of SNN stock, acquired nearly 3 million additional shares, according to regulatory filings.
BlackRock becomes a major med-tech player after Barclay’s purchase
The world’s largest asset management firm is now a major player in medical devices.
In the first of several pending moves, BlackRock Inc. (NYSE:BLK) assumed a five percent stake in several medical device firms including Boston Scientific Corp. (NYSE: BSX) and Abiomed Inc. (NSDQ:ABMD), according to a clutch of regulatory filings with the federal Securities and Exchange Commission Jan 29.
BlackRock, which controls more than $3.2 trillion in assets, assumed the stake in both firms following its purchase of Barclay’s Global Investors last December.
